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Introduction
Cerebral atrophy has been described to occur in systemic
lupus erythematosus (SLE) with variable frequency. Aging,
corticosteroid use, inflammation and central nervous sys-
tem (CNS) involvement may lead to cerebral atrophy. The
higher sera levels of cytokines in childhood-onset SLE
(cSLE) might induce cerebral alterations.
Objectives
To determine the prevalence of cerebral atrophy in cSLE
and to evaluate sera Th1 (IL-12, IFN-g, TNF-a) and Th2
(IL-4, 5, 6 and 10) cytokines levels in cSLE. To elucidate
the possible relationship between cerebral atrophy and
Th1 and Th2 cytokine profile.
Methods
We included consecutive cSLE followed at the pediatric
rheumatology unit of the State University of Campinas
were enrolled in this study. The control group was
consisted by age and sex matched healthy individuals.
A complete clinical, laboratory and neurological evaluation
was performed in all subjects. Neurological manifestations
were analyzed according to the ACR classification criteria.
Mood and anxiety disorders were determined through
Becks Depression and Becks Anxiety Inventory.SLE
patients were further assessed for clinical and laboratory
SLE manifestations, disease activity [SLE Disease Activity
Index (SLEDAI)], damage [Systemic Lupus International
Collaborating Clinics/American College of Rheumatology
Damage Index (SDI)] and current drug exposures. Total
dose of corticosteroids and other immunosuppressant
medications used since the onset of disease were calcu-
lated by data obtained by careful review of the medical
charts. MRI scans were performed in a 3T Phillips®scan-
ner using a standardized protocol. Sagittal T1 weighted
images were used for semiautomatic volumetric measure-
ments. Volumes smaller 2 standard deviation from the
means of controls were considered abnormal. Total dose
of corticosteroids and other immunosuppressant medica-
tions used since the onset of disease were calculated by
data obtained by careful review of the medical charts. Sera
samples were obtained from all participants in the absence
of infections. Th1 (IL-12, IFN-g, TNF-a) and Th2 (IL-4, 5,
6 and 10) cytokines sera levels were measured by ELISA
using commercial kits. Data were compared by non-
parametric tests.
Results
We included 76 cSLE patients (69 women; median age
16 years; range 9-30) and 66 (women 51; median age of
19 years; range 5-23) age and sex matched healthy con-
trols. The median and range cerebral volume in patients
with cSLE was 1067.9 (range 831.1-1449.2) cm3, com-
pared with 1172.7 (range 941.9-1477.1) cm3 in healthy
volunteers (p<0.001). Cerebral atrophy was identified in
18 (23.7%) cSLE patients and in 1 (1.5%) control
(p<0.001). Significantly increased Th1 [IL-12 (p=0.016),
IFN-g (p<0.001), TNF-a (p<0.001)] and Th2 [IL-4
(p=0.046), 5 (p=0.013), 6 (p<0.001) and 10 (p=0.022)]
levels were observed in SLE patients compared to
controls. We observed an association between cerebral
atrophy and IL-12 (p=0.034). We also observed an asso-
ciation between cerebral atrophy and aCL (p=0.023),
cumulative corticosteroid dose/kg (p=0.024), dsDNA
(p=0.024), anti-Sm antibodies (p=0.049) and depression
(p=0.024).
Conclusion
IL-12 was associated with cerebral atrophy in cSLE, sug-
gesting immunological basis for global atrophy in SLE.
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